CeriBell Soars 58% Ahead of $175 Million IPO: A Game Changer in Seizure Diagnostics
CeriBell, a medical device company, has increased its shares by 58% ahead of a $175 million IPO, showcasing its innovative EEG platform for seizure diagnostics.
SailPoint Technologies has raised its IPO price range to $21-$23 per share, aiming to raise $1.1 billion in its upcoming offering. The company specializes in identity governance solutions and has reported significant growth in annual recurring revenue.